Increased CX3CL1/CX3CR1 Axis Is Related to Atherosclerosis in Subjects with Familial Combined Hyperlipidaemia, Which Is Modulated by Insulin Resistance but Not by Sex
<b>Background</b>: A major factor in the development of atherosclerosis is the presence of a chronic inflammatory state. The CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis has been implicated in the development of atherosclerosis and cardiovascular disease, but until now, scarce data are available regarding the influence of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis in familial combined hyperlipidaemia (FCH). Since FCH is associated with a high risk of cardiovascular disease, the objective of the present study was to assess the presence of alterations in the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis in patients with FCH and to evaluate the influence of insulin resistance (IR) and sex. <b>Methods</b>: A cohort of 47 subjects with FCH and 38 control subjects was included. We measured the lipid profile, glucose, and insulin levels in plasma, circulating blood CX<sub>3</sub>CL1 levels, and CX<sub>3</sub>CR1 mRNA expression. Carotid IMT and the presence of atheroma plaques were also evaluated. <b>Results</b>: FCH subjects showed significantly higher activation of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis than controls. In addition, FCH individuals with IR showed the worst profile of inflammation status, higher carotid IMT, and a higher prevalence of atherosclerotic plaque compared to controls and FCH patients without IR. However, sex did not influence the CX3CL1/CX3CR1 axis. <b>Conclusions</b>: FCH patients showed an increased CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis, which was positively correlated with IR, but not with sex. These data could partially explain the increased risk of cardiovascular events in primary dyslipidemic patients.
Authors
- Gema Hurtado-Genovés (ORCID: https://orcid.org/0000-0002-3408-8501)
- E. Nadal (ORCID: https://orcid.org/0000-0002-6864-5994)
- Blanca Alabadí (ORCID: https://orcid.org/0000-0001-5129-6954)
- Sergio Martínez‐Hervás (ORCID: https://orcid.org/0000-0002-6775-2034)
- Elena Jiménez-Martí (ORCID: https://orcid.org/0000-0002-1537-5337)
- Villalpando Casas
- Susana Martín-Vañó (ORCID: https://orcid.org/0000-0001-5515-6916)
- Herminia González‐Navarro (ORCID: https://orcid.org/0000-0001-6883-3808)
- José T. Real
- Clara Espinosa-Bellido
- Antonio Enrique-Medina
Institutions
- Universitat de València (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Hospital Clínico Universitario de Valencia (ES)
- INCLIVA Health Research Institute (ES)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-09-28
- DOI
- https://doi.org/10.3390/biomedicines13102378
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00